Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.

Ivana K. Kim,Anne Marie Lane,Jain P,Caroline Awh,Evangelos S. Gragoudas

Transactions of the American Ophthalmological Society（2016）

引用 47|浏览6

暂无评分

摘要

In this small pilot study, prophylactic ranibizumab appears generally safe in patients treated with proton irradiation for choroidal melanoma. High rates of visual acuity retention were observed through 2 years.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要